Cargando…
Cardiovascular Risk Among Patients with Controlled and Uncontrolled Type 2 Diabetes: A Sub-Cohort Analysis from the Heart Health Promotion (HHP) Study
OBJECTIVE: This study aimed to estimate the risk of cardiovascular disease (CVD) among patients with and without diabetes mellitus (DM) using the Framingham risk score (FRS) and to investigate the effect of DM control on CVD risk. METHODOLOGY: A total of 2432 participants who had their glycosylated...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075213/ https://www.ncbi.nlm.nih.gov/pubmed/37033207 http://dx.doi.org/10.2147/IJGM.S404054 |
_version_ | 1785019876238163968 |
---|---|
author | Fayed, Amel Alzeidan, Rasmieh Elkouny, Roaa Tawfik, Marwa Naguib, Rania |
author_facet | Fayed, Amel Alzeidan, Rasmieh Elkouny, Roaa Tawfik, Marwa Naguib, Rania |
author_sort | Fayed, Amel |
collection | PubMed |
description | OBJECTIVE: This study aimed to estimate the risk of cardiovascular disease (CVD) among patients with and without diabetes mellitus (DM) using the Framingham risk score (FRS) and to investigate the effect of DM control on CVD risk. METHODOLOGY: A total of 2432 participants who had their glycosylated hemoglobin (HbA1c) measured within the last three months were included in this study. The study cohort was divided into three categories: non-diabetic, participants with controlled DM (HbA1c<7%), and uncontrolled DM (HbA1c≥7%). The World Health Organization’s stepwise approach to chronic disease risk factor Surveillance-Instrument v2.1 was used in this study to collect the anthropometric and biochemical measurements. The Framingham Coronary Heart Risk Score (FRS) was used to calculate the 10-year cardiovascular risk (CVR). The groups were compared concerning the prevalence of metabolic, socioeconomic, and cardiac risks. RESULTS: Out of 2432 participants, 149 had controlled DM (6.1%), 286 had uncontrolled DM (11.8%), and 1997 participants were normoglycemic (82.1%). Compared to healthy participants, diabetic participants showed more high-risk characteristics across all CVR parameters. Uncontrolled diabetic patients had a graver laboratory and clinical profiles compared to the controlled DM group. As measured by FRS, nearly half of patients with controlled DM (49.9%) and two-thirds of patients with uncontrolled DM (63.3%) were classified as intermediate and high-risk compared to 4.6% of the healthy participants. Compared to healthy participants, patients with controlled DM showed a threefold increased CVR (OR = 3.02, 95% C.I. = 1.41–7.24) while this risk catapulted to 13 times among those with uncontrolled DM (OR = 13.57, 95% C.I. = 6.99–26.36). CONCLUSION: Participants with DM are at moderate to high CVR. Individuals with uncontrolled DM showed higher CVR profiles as measured by FRS and have a higher prevalence of obesity, unhealthy diet, and physical inactivity. |
format | Online Article Text |
id | pubmed-10075213 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-100752132023-04-06 Cardiovascular Risk Among Patients with Controlled and Uncontrolled Type 2 Diabetes: A Sub-Cohort Analysis from the Heart Health Promotion (HHP) Study Fayed, Amel Alzeidan, Rasmieh Elkouny, Roaa Tawfik, Marwa Naguib, Rania Int J Gen Med Original Research OBJECTIVE: This study aimed to estimate the risk of cardiovascular disease (CVD) among patients with and without diabetes mellitus (DM) using the Framingham risk score (FRS) and to investigate the effect of DM control on CVD risk. METHODOLOGY: A total of 2432 participants who had their glycosylated hemoglobin (HbA1c) measured within the last three months were included in this study. The study cohort was divided into three categories: non-diabetic, participants with controlled DM (HbA1c<7%), and uncontrolled DM (HbA1c≥7%). The World Health Organization’s stepwise approach to chronic disease risk factor Surveillance-Instrument v2.1 was used in this study to collect the anthropometric and biochemical measurements. The Framingham Coronary Heart Risk Score (FRS) was used to calculate the 10-year cardiovascular risk (CVR). The groups were compared concerning the prevalence of metabolic, socioeconomic, and cardiac risks. RESULTS: Out of 2432 participants, 149 had controlled DM (6.1%), 286 had uncontrolled DM (11.8%), and 1997 participants were normoglycemic (82.1%). Compared to healthy participants, diabetic participants showed more high-risk characteristics across all CVR parameters. Uncontrolled diabetic patients had a graver laboratory and clinical profiles compared to the controlled DM group. As measured by FRS, nearly half of patients with controlled DM (49.9%) and two-thirds of patients with uncontrolled DM (63.3%) were classified as intermediate and high-risk compared to 4.6% of the healthy participants. Compared to healthy participants, patients with controlled DM showed a threefold increased CVR (OR = 3.02, 95% C.I. = 1.41–7.24) while this risk catapulted to 13 times among those with uncontrolled DM (OR = 13.57, 95% C.I. = 6.99–26.36). CONCLUSION: Participants with DM are at moderate to high CVR. Individuals with uncontrolled DM showed higher CVR profiles as measured by FRS and have a higher prevalence of obesity, unhealthy diet, and physical inactivity. Dove 2023-04-01 /pmc/articles/PMC10075213/ /pubmed/37033207 http://dx.doi.org/10.2147/IJGM.S404054 Text en © 2023 Fayed et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Fayed, Amel Alzeidan, Rasmieh Elkouny, Roaa Tawfik, Marwa Naguib, Rania Cardiovascular Risk Among Patients with Controlled and Uncontrolled Type 2 Diabetes: A Sub-Cohort Analysis from the Heart Health Promotion (HHP) Study |
title | Cardiovascular Risk Among Patients with Controlled and Uncontrolled Type 2 Diabetes: A Sub-Cohort Analysis from the Heart Health Promotion (HHP) Study |
title_full | Cardiovascular Risk Among Patients with Controlled and Uncontrolled Type 2 Diabetes: A Sub-Cohort Analysis from the Heart Health Promotion (HHP) Study |
title_fullStr | Cardiovascular Risk Among Patients with Controlled and Uncontrolled Type 2 Diabetes: A Sub-Cohort Analysis from the Heart Health Promotion (HHP) Study |
title_full_unstemmed | Cardiovascular Risk Among Patients with Controlled and Uncontrolled Type 2 Diabetes: A Sub-Cohort Analysis from the Heart Health Promotion (HHP) Study |
title_short | Cardiovascular Risk Among Patients with Controlled and Uncontrolled Type 2 Diabetes: A Sub-Cohort Analysis from the Heart Health Promotion (HHP) Study |
title_sort | cardiovascular risk among patients with controlled and uncontrolled type 2 diabetes: a sub-cohort analysis from the heart health promotion (hhp) study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075213/ https://www.ncbi.nlm.nih.gov/pubmed/37033207 http://dx.doi.org/10.2147/IJGM.S404054 |
work_keys_str_mv | AT fayedamel cardiovascularriskamongpatientswithcontrolledanduncontrolledtype2diabetesasubcohortanalysisfromthehearthealthpromotionhhpstudy AT alzeidanrasmieh cardiovascularriskamongpatientswithcontrolledanduncontrolledtype2diabetesasubcohortanalysisfromthehearthealthpromotionhhpstudy AT elkounyroaa cardiovascularriskamongpatientswithcontrolledanduncontrolledtype2diabetesasubcohortanalysisfromthehearthealthpromotionhhpstudy AT tawfikmarwa cardiovascularriskamongpatientswithcontrolledanduncontrolledtype2diabetesasubcohortanalysisfromthehearthealthpromotionhhpstudy AT naguibrania cardiovascularriskamongpatientswithcontrolledanduncontrolledtype2diabetesasubcohortanalysisfromthehearthealthpromotionhhpstudy |